These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20001575)

  • 1. Evaluating patient satisfaction with specific migraine therapy based on initial treatment expectations: the PAX study.
    Lantéri-Minet M; Allain H; Druais PL; Meric G; Troy S
    Curr Med Res Opin; 2010 Feb; 26(2):465-72. PubMed ID: 20001575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute migraine treatment: patterns of use and satisfaction in a clinical population.
    Malik SN; Hopkins M; Young WB; Silberstein SD
    Headache; 2006 May; 46(5):773-80. PubMed ID: 16643580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmarketing migraine survey of frovatriptan: effectiveness and tolerability vs previous triptans, NSAIDs or a combination.
    Cady RK; Banks J; Jones BA; Campbell J
    Curr Med Res Opin; 2009 Nov; 25(11):2711-21. PubMed ID: 19778164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The acute treatment of episodic and chronic migraine in the USA.
    Bigal ME; Borucho S; Serrano D; Lipton RB
    Cephalalgia; 2009 Aug; 29(8):891-7. PubMed ID: 19222509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Migraine treatment with rizatriptan and non-triptan usual care medications: a pharmacy-based study.
    Cady R; Martin V; Adelman J; Diamond M; Sajjan S; Hu XH
    Headache; 2004 Oct; 44(9):900-7. PubMed ID: 15447699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.
    Bell CF; Foley KA; Barlas S; Solomon G; Hu XH
    Clin Ther; 2006 Jun; 28(6):872-80. PubMed ID: 16860170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining the utility of in-clinic "rescue" therapy for acute migraine.
    Morey V; Rothrock JF
    Headache; 2008 Jun; 48(6):939-43. PubMed ID: 18549372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consistent efficacy, tolerability, and high levels of satisfaction with almotriptan 12.5 mg when used to treat multiple migraine attacks in routine clinical practice.
    Diener HC
    Headache; 2005 Jun; 45(6):624-31. PubMed ID: 15953293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
    Schreiber CP; Cady RK
    Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of children with migraine in emergency departments: national practice variation study.
    Richer LP; Laycock K; Millar K; Fitzpatrick E; Khangura S; Bhatt M; Guimont C; Neto G; Noseworthy S; Siemens R; Gouin S; Rowe BH;
    Pediatrics; 2010 Jul; 126(1):e150-5. PubMed ID: 20530076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral transmucosal fentanyl citrate for the treatment of migraine headache pain in outpatients: a case series.
    Landy SH
    Headache; 2004 Sep; 44(8):762-6. PubMed ID: 15330821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use and overuse of antimigraine drugs by pharmacy personnel in France: COTA survey.
    Donnet A; Lantéri-Minet M; Aucoin F; Allaf B
    Headache; 2009 Jul; 49(7):1014-21. PubMed ID: 19486362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of the acute migraine headache.
    Aukerman G; Knutson D; Miser WF;
    Am Fam Physician; 2002 Dec; 66(11):2123-30. PubMed ID: 12484694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of antimigraine treatments by general practitioners.
    Ducros A; Romatet S; Saint Marc T; Allaf B
    Headache; 2011; 51(7):1122-31. PubMed ID: 21675969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical care for migraine and headache patients: a community-based, randomized intervention.
    Hoffmann W; Herzog B; Mühlig S; Kayser H; Fabian R; Thomsen M; Cramer M; Fiss T; Gresselmeyer D; Janhsen K
    Ann Pharmacother; 2008 Dec; 42(12):1804-13. PubMed ID: 19001531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment.
    Bigal ME; Serrano D; Reed M; Lipton RB
    Neurology; 2008 Aug; 71(8):559-66. PubMed ID: 18711108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rofecoxib versus ibuprofen for acute treatment of migraine: a randomised placebo controlled trial.
    Misra UK; Jose M; Kalita J
    Postgrad Med J; 2004 Dec; 80(950):720-3. PubMed ID: 15579612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Underdiagnosis and undertreatment of migraine in Italy: a survey of patients attending for the first time 10 headache centres.
    Cevoli S; D'Amico D; Martelletti P; Valguarnera F; Del Bene E; De Simone R; Sarchielli P; Narbone M; Testa L; Genco S; Bussone G; Cortelli P
    Cephalalgia; 2009 Dec; 29(12):1285-93. PubMed ID: 19438916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes.
    Bigal ME; Rapoport AM; Sheftell FD; Tepper SJ; Lipton RB
    Cephalalgia; 2004 Jun; 24(6):483-90. PubMed ID: 15154858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.